Florfenicol

This classification denotes a protein synthesis inhibitor and antibiotic with the molecular formula C12H14Cl2FNO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9J97307Y1H, chemically known as 2,2-dichloro-n-(1-(fluoromethyl)-2-hydroxy-2-(4-(methylsulfonyl)phenyl)ethyl)acetamide but generally known as florfenicol, which bears US NIH Compound Identifier 114811. European Medicines Agency schedules Florfenicol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07651MIG. The term FLORFENICOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). FLORFENICOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule florfenicol under HS 29414000 and SITC 54139. As of Q4 2014, FLORFENICOL remains the US FDA Preferred Term for this commodity. Florfenicol bears US NLM identifiers UMLS ID C0060466 and NCI Concept Code C75146. SMILES: CS(=O)(=O)C1=CC=C(C=C1)C(C(CF)NC(=O)C(CL)CL)O.